ERFA Biotech - Specializes in Research, Development and Commercialization of Monoclonal Antibodies (mAb)
- 1935 - ERFA SA - founded in Brussels
- 1968 - Roussel Uclaf acquired ERFA and invested
in its Belgian Production Plant
- 1996 - Acquisition by Associated Boosters &
Development of own Product Portfolio as of 1997
- 1998 - Erfa Canada Inc.- Startup of Portal to
North-American Market
- 1999 - Erfa Biotech - Acquisition of “Clinical”
and “Research” Monoclonal Antibodies from Rougier Biotech in Montreal
- 2001 - ProFuMab - created as the R&D Division of Erfa BioTech
 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
|
||||
 |
 |
 |
 |
 |
|
||||
 |
|
||||||||